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Community transmission of inﬂ  uenza  A  pandemic 
(H1N1) 2009 was followed by high rates of hospital admis-
sions in the Wellington region of New Zealand, particularly 
among Maori and Paciﬁ  c  Islanders.  These  ﬁ  ndings  may 
help health authorities anticipate the effects of pandemic 
(H1N1) 2009 in other communities.
S
pread of inﬂ  uenza A pandemic (H1N1) 2009 virus co-
incided with the Southern Hemisphere winter, leading 
to outbreaks in Australia and New Zealand (NZ) (1). Quan-
tifying the number of admissions and the age, ethnicity, and 
medical conditions of patients admitted to hospitals in the 
Wellington region because of acute illness during the ﬁ  rst 
wave of pandemic (H1N1) 2009 provides valuable infor-
mation to health authorities anticipating the impact of the 
pandemic in other regions.
The Study
Patients suspected of having inﬂ  uenza and requiring 
hospital assessment were tested with real-time reverse 
transcription–PCR by using protocols from the US Cen-
ters for Disease Control and Prevention (2). This analysis 
included only persons (case-patients) with conﬁ  rmed pan-
demic (H1N1) 2009 who were admitted to public hospi-
tal beds in the NZ Wellington and Hutt Valley regions. 
The results of viral testing were not available at the time 
of admission and therefore did not affect decisions about 
admission.
We identiﬁ   ed case-patients by matching laboratory 
and hospital patient information systems. Sex, age, clini-
cal service, inpatient mortality, and self-reported ethnicity 
were available, as was limited information about medical 
conditions. Ethnicity data were aggregated as NZ Euro-
pean, Maori, Paciﬁ  c Islanders, or other (i.e., all other and 
unspeciﬁ   ed ethnicities combined). Admission rates per 
100,000 persons were calculated using regional denomina-
tor data from the 2006 NZ Census (3) and age standardized 
by a direct method using 10-year age groups.
Testing for pandemic (H1N1) 2009 began on April 24, 
2009, and local community transmission was detected in 
the Wellington region early in June. During June 8–August 
31, pandemic (H1N1) 2009 was identiﬁ  ed in 229 hospital-
ized case-patients. Hospitalizations began in June, peaked 
in July, and then declined rapidly (Figure 1). The mean age 
of admitted persons was 26 years (range 0–82 years); 62% 
were <30 years of age. A total of 117 (51%) admissions 
were under adult medical services, 79 (34%), under pediat-
ric medical services, and 15 (7%), under obstetric services. 
Mean duration of admission was 6.1 days (range 0–24 days) 
and 111 (48%) patients stayed in hospital for <72 hours 
(Figure 2). Nineteen (8%) case-patients were admitted to 
intensive care or high dependency units for at least 1 night. 
Five (2%) case-patients died during their hospital stay; all 
of these deaths were attributed to pandemic (H1N1) 2009.
Seventy-four (32%) case-patients were NZ European, 
70 (31%) were Maori, 64 (28%) were Paciﬁ  c Islanders, 17 
(7%) were other, and 4 (2%) were unspeciﬁ  ed. The rate of 
admission for NZ Europeans in the Wellington region was 
25.6 per 100,000. Age-adjusted rates for Paciﬁ  c Islanders 
and Maori were 180 and 128 per 100,000, respectively.
Ninety-one (40%) of the total group had a chronic lung 
condition; of these, 58 (64%) had asthma. For 116 (51%), 
a preexisting medical condition was described in the dis-
charge summary. Eighteen women were either pregnant or 
immediately postpartum during their hospital stays. Rates 
of chronic respiratory conditions were lower for Paciﬁ  c Is-
landers than for Maori or all others (28%, 41%, and 48%, 
respectively) (Table). Ethnicity and presence of a chronic 
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Figure 1. Number of hospitalizations for pandemic (H1N1) 2009, by 
date of admission, Wellington region, New Zealand, June–August 
2009.Hospitalizations for Pandemic (H1N1) 2009
respiratory condition were dependent (χ2 = 6.22, 2 df, p = 
0.044). Rates of other medical conditions for Paciﬁ  c Is-
landers, Maori, and all others were 56%, 41%, and 54% 
(independent χ2 = 3.67, 2 df, p = 0.16).
Conclusions
The Wellington region had higher population-adjusted 
hospitalization rates for pandemic (H1N1) 2009 than did 
New Zealand and countries overseas (4). In Australia, the 
reported rate of hospitalizations was one third that in our 
region (5). Local testing or referral patterns may have con-
tributed to more admissions in a variety of ways. First, our 
rates of laboratory conﬁ  rmation may be higher because of 
ready access to timely PCR results (6), facilitating inves-
tigation and case detection in persons admitted to a hospi-
tal. NZ hospitals are unlikely to have a lower threshold for 
admission than Australian hospitals. Although both coun-
tries have free access to hospital care for pandemic (H1N1) 
2009, NZ hospitals are always busy in the winter, so clini-
cal services attempt to manage patients in the community 
wherever possible.
Our study shows that Paciﬁ  c Islanders and Maori were 
7 and 5 times more likely, respectively, than NZ Europeans 
to require hospital admission. These ﬁ  ndings are consistent 
with observations from previous inﬂ  uenza epidemics. Dur-
ing the 1918 pandemic, the death rate was 7-fold higher 
in Maori than in the NZ Europeans (7). In Samoa in 1918, 
80% of the population was considered infected, and 7,264 
died from a total population of 36,405 (8). Other indig-
enous communities, such as Aboriginals in Australia and 
Inuit in Canada, also appear to have higher rates of severe 
inﬂ  uenza-related illness (9).
Factors other than disease severity may contribute to 
admissions. A higher incidence of pandemic (H1N1) 2009 
in Paciﬁ  c Islanders or Maori households is likely to have 
led to greater representation across the spectrum of clinical 
manifestations, including severe disease (Environmental 
Science and Research, unpub. data). This explanation is 
supported by national surveillance, which demonstrated 
higher rates of conﬁ  rmed pandemic (H1N1) 2009 in Maori 
and Paciﬁ  c Islanders. However, this ﬁ  nding depends heavi-
ly on community testing, which was never uniformly avail-
able across NZ and ceased to be offered routinely once NZ 
switched to a manage-it phase (10). An alternative cause of 
higher rates in Paciﬁ  c Islanders or Maori may be a greater 
readiness to self-refer to an emergency department for as-
sessment when unwell.
This study does not address why severe inﬂ  uenza is 
more frequently observed in Paciﬁ  c Islanders and Maori. 
We did not observe higher rates of preexisting medical 
conditions in the hospitalized Maori and Paciﬁ  c Islanders 
and noted lower rates of chronic respiratory conditions in 
Paciﬁ  c Islanders. However, other conditions were detected 
only on discharge summary review and not by screening 
or systematic questioning; thus other undocumented condi-
tions may contribute to ethnic disparity in hospitalizations. 
A comparison of seropositivity rates in representative sec-
tions of high- and low-risk communities is needed to ascer-
tain whether high hospitalization rates resulted from high 
rates of community transmission, preexisting conditions, or 
higher rates of complications of inﬂ  uenza. Future control 
strategies, including primary prevention or improved ac-
cess to timely treatment, could then be reﬁ  ned to the needs 
of Maori and Paciﬁ  c Islanders. In any case, targeting vac-
cination to the elderly and persons with known comorbid 
conditions will fail to protect a substantial minority of per-
sons who need hospital care and will particularly disadvan-
tage Paciﬁ  c Islanders.
The observed age distribution is consistent with other 
reports describing acute pandemic (H1N1) 2009 (11). Most 
admissions were for only a few days, but a substantial mi-
nority of hospitalized case-patients required care for sev-
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Figure 2. Duration of hospitalization for case-patients with pandemic 
(H1N1) 2009, Wellington region, New Zealand, June–August 
2009.
Table. Characteristics of 229 persons hospitalized with influenza A pandemic (H1N1) 2009 (case-patients), Wellington region, New
Zealand, June–August 2009 
Ethnic group
No. case-
patients
Age-adjusted hospitalization 
rate per 100,000
Median
age, y
No. (%) case-patients with 
chronic lung condition 
No. (%)case-patients with 
other medical condition
Pacific Islanders 64 180 15.5 18 (28) 36 (56)
Maori 70 128 23.5 29 (41) 29 (41)
Other* 95 25.6 29 45 (47) 44 (46)
*All other and unspecified ethnicities combined. eral weeks. Most new admissions were conﬁ  ned to 1 month 
at the start of winter.
Pandemic (H1N1) 2009 has resulted in hospital ad-
missions and severe illness in our study population more 
frequently than reported elsewhere. What proportion is 
due to good access to nucleic acid-based testing, local dis-
ease transmission dynamics, or intrinsic susceptibility of 
our population to the virus is not clear. Nonetheless, our 
ﬁ  ndings will interest those planning health services inter-
nationally, including other areas serving Paciﬁ  c Islanders 
and indigenous communities.
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